As of October 2024, Biocon has a market cap of $5.20B. This makes Biocon the world's 2709th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $3.92B | 9.87% |
2023 | $3.57B | -4.66% |
2022 | $3.74B | -28.19% |
2021 | $5.21B | -21.65% |
2020 | $6.65B | 58.46% |
2019 | $4.20B | -6.62% |
2018 | $4.49B | 17.08% |
2017 | $3.84B | 69.70% |
2016 | $2.26B | 83.33% |
2015 | $1.23B | 21.75% |
2014 | $1.01B | -8.04% |
2013 | $1.10B | 61.35% |
2012 | $683.03M | 4.73% |
2011 | $652.19M | -34.93% |
2010 | $1.00B | 52.45% |
2009 | $657.42M | 136.85% |
2008 | $277.57M | -59.62% |
2007 | $687.31M | 54.46% |
2006 | $444.99M | -24.53% |
2005 | $589.61M | -2.72% |
2004 | $606.10M | - |